SUNACE
SUNACE
Quality Trends Assay · 26 releases
July 2026 close · posted live Mon 3 Aug 2026

Manufacturing

Quality Trends

Every release in the order it was made, against its specification limits.

Releases plotted

26

ACE-MGS 20 PH · magnesium stearate, pharmaceutical grade

Average assay

99.61%

Specification 98.00 to 101.50% · target 99.60%

+0.01 against target

Outside specification

0

Every release inside its limits

Clean run

Process capability, Cpk

1.46

Comfortably inside the limits

σ 0.37%

Assay by batch, in the order it was made

Red bands are the specification limits, the dashed line is target.

Inside spec Near a limit Out of spec
97.58 98.66 99.75 100.84 101.92 Upper 101.50% Lower 98.00% Target 99.60% B25-0704 · ACE-MGS20-PH · 11 Aug 2025 · 99.87% B25-0738 · ACE-MGS20-PH · 20 Aug 2025 · 99.46% · -0.41 on the job before B25-0736 · ACE-MGS20-PH · 23 Aug 2025 · 99.30% · -0.16 on the job before B25-0801 · ACE-MGS20-PH · 09 Sep 2025 · 99.08% · -0.22 on the job before B25-0817 · ACE-MGS20-PH · 09 Oct 2025 · 99.75% · +0.67 on the job before B25-0818 · ACE-MGS20-PH · 16 Oct 2025 · 100.08% · +0.33 on the job before B25-0845 · ACE-MGS20-PH · 18 Oct 2025 · 99.63% · -0.45 on the job before B25-0820 · ACE-MGS20-PH · 20 Oct 2025 · 99.16% · -0.47 on the job before B25-0804 · ACE-MGS20-PH · 23 Oct 2025 · 99.61% · +0.45 on the job before B25-0803 · ACE-MGS20-PH · 24 Oct 2025 · 99.34% · -0.27 on the job before B25-0856 · ACE-MGS20-PH · 03 Nov 2025 · 99.93% · +0.59 on the job before B25-0943 · ACE-MGS20-PH · 04 Dec 2025 · 99.94% · +0.01 on the job before B25-0941 · ACE-MGS20-PH · 16 Dec 2025 · 100.02% · +0.08 on the job before B25-0902 · ACE-MGS20-PH · 22 Dec 2025 · 99.40% · -0.62 on the job before B26-0067 · ACE-MGS20-PH · 06 Jan 2026 · 99.11% · -0.29 on the job before B26-0082 · ACE-MGS20-PH · 13 Jan 2026 · 99.90% · +0.79 on the job before B26-0079 · ACE-MGS20-PH · 26 Jan 2026 · 99.05% · -0.85 on the job before B26-0132 · ACE-MGS20-PH · 07 Feb 2026 · 100.15% · +1.10 on the job before B26-0124 · ACE-MGS20-PH · 08 Feb 2026 · 99.24% · -0.91 on the job before B26-0173 · ACE-MGS20-PH · 08 Mar 2026 · 100.13% · +0.89 on the job before B26-0278 · ACE-MGS20-PH · 18 May 2026 · 99.97% · -0.16 on the job before B26-0306 · ACE-MGS20-PH · 22 Jun 2026 · 99.59% · -0.38 on the job before B26-0352 · ACE-MGS20-PH · 01 Jul 2026 · 99.96% · +0.37 on the job before B26-0379 · ACE-MGS20-PH · 08 Jul 2026 · 99.34% · -0.62 on the job before B26-0369 · ACE-MGS20-PH · 10 Jul 2026 · 99.07% · -0.27 on the job before B26-0365 · ACE-MGS20-PH · 19 Jul 2026 · 99.68% · +0.61 on the job before Aug 2025 Sep 2025 Oct 2025 Nov 2025 Dec 2025 Jan 2026 Feb 2026 Mar 2026 May 2026 Jun 2026 Jul 2026

Nothing outside the limits

Every assay release in this run sat inside its specification.

The biggest movement in the run

The largest change from one job to the next.

B26-0079
26 Jan 2026 · RX-03, Malcolm Rees
ACE-MGS20-PH · 1,950 kg
99.05%
B26-0132
07 Feb 2026 · RX-03, Anthony Jarvis
ACE-MGS20-PH · 1,941 kg
100.15%
+1.10 on the job before
B26-0124
08 Feb 2026 · RX-03, Sione Naufahu
ACE-MGS20-PH · 1,947 kg
99.24%
WO-2026-0132 ran on RX-03 under Anthony Jarvis.